SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-18-002042
Filing Date
2018-03-14
Accepted
2018-03-14 10:29:50
Documents
94
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K qure-20171231x10k.htm 10-K 4009056
2 EX-10.4 qure-20171231ex104b5fe75.htm EX-10.4 63880
3 EX-10.5 qure-20171231ex105a0e6b6.htm EX-10.5 76613
4 EX-21.1 qure-20171231ex21123b305.htm EX-21.1 8255
5 EX-23.1 qure-20171231ex2315ee8fe.htm EX-23.1 5237
6 EX-31.1 qure-20171231ex3118b0196.htm EX-31.1 18631
7 EX-31.2 qure-20171231ex3120ea062.htm EX-31.2 18631
8 EX-32.1 qure-20171231ex321be04da.htm EX-32.1 11824
  Complete submission text file 0001558370-18-002042.txt   14912109

Data Files

Seq Description Document Type Size
9 EX-101.INS qure-20171231.xml EX-101.INS 3486251
10 EX-101.SCH qure-20171231.xsd EX-101.SCH 92861
11 EX-101.CAL qure-20171231_cal.xml EX-101.CAL 83811
12 EX-101.DEF qure-20171231_def.xml EX-101.DEF 402725
13 EX-101.LAB qure-20171231_lab.xml EX-101.LAB 769236
14 EX-101.PRE qure-20171231_pre.xml EX-101.PRE 660566
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-36294 | Film No.: 18688560
SIC: 2834 Pharmaceutical Preparations